Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age group between 5 to 12 years 2) Patient irrespective of their gender, religion and socio-economic status 3) Patients having symptoms of ADHD for at least last 6 months 4) Symptoms must have appeared before the age of 12 years. 5) Patients that fit in DSM IV criteria for diagnosis.
Exclusion criteria
Exclusion criteria: 1)Any serious neurological disease diagnosed earlier like cerebral palsy, mental retardation, microcephaly 2)Any kind of known systemic disease or chronic systemic disease like nephrotic syndrome, type 1 diabetes mellites. 3)Patients that do not fit in DSM 4 criteria for diagnosis 4)Parents not giving consent for treatment 5)Patient should not be on any other intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Study the Efficacy of Panchendriya vardhan Taila Nasya in reducing symptoms of attention deficit hyperactivity disorder (ADHD) in children aged 5-12 years given over a period of 21 days.Timepoint: Treatment will be given for 21 days Follow up and assessment will be done on 0th 14th 21st 31st 45th day | — |
Secondary
| Measure | Time frame |
|---|---|
| To monitor the safety and tolerability of Panchendriya Vardhan Taila Nasya in children. To assess the impact of Panchendriya Vardhan Taila Nasya on the sleep quality of ADHD children.Timepoint: Treatment will be given for 21 days Follow up and assessment will be done on 0th 14th 21st 31st 45th day | — |
Countries
India
Contacts
MAM Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune